Risperdal Settlements

risperdal settlementsJohnson & Johnson and its Janssen Pharmaceuticals unit have faced mounting lawsuits over Risperdal and its potential to cause gynecomastia, a condition marked by excessive male breast growth. While Risperdal settlements and verdicts have been reported in some cases, hundreds of lawsuits remain to be adjudicated.

Filing a Risperdal Lawsuit Can Help

If you or someone you care about developed gynecomastia while using Risperdal, filing a lawsuit against the drug’s manufacturers may allow you to obtain compensation for the cost of corrective surgery and any related damages. Bernstein Liebhard LLP is already representing a number of Risperdal plaintiffs, and our attorneys are offering free legal reviews to anyone who may have been harmed by this drug. To learn more, please contact our legal staff by calling (888) 994-5118.

Risperdal Verdicts and Settlements

Hundred of Risperdal cases have been filed over the drug’s association with male breast development in a mass tort litigation currently underway in Pennsylvania’s Philadelphia Court of Common Pleas. Verdicts and settlement have been reached in some of these lawsuits.

  • July 2016: A Pennsylvania jury unanimously rules in favor of a fifth gynecomastia plaintiff, and orders Johnson & Johnson to pay $70 million to a teenager who developed the condition while using Risperdal. The compensatory damage award is the largest so far in a case involving Risperdal  male breast growth. Read More
  • December 2015: Pennsylvania’s fourth Risperdal gynecomastia trial concludes with the jury finding that the drug’s manufacturers failed to provide doctors and patients with adequate warnings regarding its potential to cause excessive male breast development. The plaintiff, who was prescribed the drug off-label to treat Tourette’s syndrome, is awarded $500,000 in compensatory damages.
  • November 2015: A Pennsylvania jury awards nearly $1.8 million to a plaintiff who had been prescribed Risperdal as a child to treat autism. Testimony continues in another gynecomastia trial that began in the litigation in October. Read More
  • May 2015: Just hours before the trial is to start, an undisclosed settlement is reached in the Risperdal lawsuit chosen for Pennsylvania’s third gynecomastia trial. Read More
  • March 2015: Pennsylvania’s second Risperdal trial concludes, with the jury ruling that Janssen Pharmaceuticals’ label warnings pertaining to male breast growth were inadequate. However, the plaintiff received no damages, as the jury was unable to determine whether or not Risperdal caused his condition. Read More
  • February 2015: The first Risperdal trial involving male breast growth gets underway in Pennsylvania. The plaintiff, an autistic man who was prescribed the medication a boy, is awarded $2.5 million at the conclusion of the case. Read More
  • October 2012: Confidential settlements are reached in five male breast growth cases that were slated to go to trial in Philadelphia.
  • September 2012: Johnson & Johnson enters into an undisclosed settlement in the first gynecomastia lawsuit set to go to trial in Pennsylvania.

Johnson & Johnson Pays $2.2 Billion to Settle Federal Drug Marketing Charges

In 2013, Johnson & Johnson and Janssen agreed to pay $2.2 billion in a settlement with the U.S. Department of Justice (DOJ) in order to resolve charges that it had improperly marketed a number of medications, including Risperdal. The accord was the third-largest pharmaceutical settlement in United States history.

As part of the settlement, Johnson & Johnson agreed to plead guilty to a criminal misdemeanor, and admit that it improperly marketed Risperdal to older adults for unapproved uses. The company did not admit any wrongdoing in settling civil charges that it had marketed Risperdal for unapproved pediatric uses.

“The conduct at issue in this case jeopardized the health and safety of patients and damaged the public trust,” Attorney General Eric Holder said in a statement.  “This multibillion-dollar resolution demonstrates the Justice Department’s firm commitment to preventing and combating all forms of health care fraud.  And it proves our determination to hold accountable any corporation that breaks the law and enriches its bottom line at the expense of the American people.

Learn More about Filing a Risperdal Lawsuit

Legal help is available for men and boys who experienced excessive breast development while using Risperdal. To schedule your free legal review, please contact Bernstein Liebhard LLP by calling (888) 994-5118.

  1. Bloomberg News (2012) “J&J Settles Risperdal Lawsuit on Opening Day of Trial” http://www.bloomberg.com/news/articles/2012-09-10/j-j-settles-risperdal-lawsuit-on-opening-day-of-trial
  2. Bloomberg News (2012) “Johnson & Johnson Agrees to Settle Five Risperdal Suits” http://www.bloomberg.com/news/articles/2012-10-04/johnson-johnson-agrees-to-settle-five-rispersal-suits
  3. DOJ (2013) “Johnson & Johnson to Pay More Than $2.2 Billion to Resolve Criminal and Civil Investigations” http://www.justice.gov/opa/pr/johnson-johnson-pay-more-22-billion-resolve-criminal-and-civil-investigations


Last Modified: July 13, 2016

Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.


Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content